NCT03522545View on ClinicalTrials.gov

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 20, 2022

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Treatment-resistant Bipolar Depression
Interventions
BIOLOGICAL

Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)

Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) isolated from hematogenous bone marrow

BIOLOGICAL

Placebo

Placebo for Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)

Trial Locations (1)

77054

RECRUITING

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER